# Cancer Fund

> Cancer Fund is a VC fund in Phoenix backing Health Care and Medical. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Phoenix, United States
- Total investments: 3
- Last investment: Dec 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/thecancerfund/
- X (Twitter): https://twitter.com/CancerFundUS
- Website: https://cancerfund.com/
- Facebook: https://www.facebook.com/CancerFundUS

Cancer Fund is a VC fund in Phoenix focused on Health Care and Medical. Cancer Fund aims to generate impact and returns by advancing cancer innovations beyond research toward, or through, regulatory approvals, technical validation, or earliest market adoption. FUND I is designed to make up to $30M in pre-seed through Series D investors in therapies & management, diagnostic & monitoring, and prevention &enabling technology solutions with the potential to improve patient outcomes, increase access to care, or reduce cost of care.

## Contacts

5 contacts available for Cancer Fund. Shizune tracks 8 team members at Cancer Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cancer-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Medical | 1 | 33% |
| Biotechnology | 1 | 33% |
| Medical Device | 1 | 33% |
| Health Diagnostics | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Funding Round | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ajay Bhatnagar | Chief Medical Officer | 0 | — |
| Anita Gupta | Venture Partner | 0 | — |
| Ann Low | Co-Founder | 0 | — |
| Edward Cho | Venture Partner | 0 | — |
| Jeff Rea | Co-Founder | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cellens | Cellens is a medical device company that provides clarity and focus on cancer detection. Cellens is a Tufts University spinoff company dedicated to providing patients and doctors with clarity and confidence through noninvasive cancer screening. It was founded in 2019 and is based in Medford, Massachusetts. | $6.5M | Seed | Dec 23, 2025 |  |
| AOA | AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M |  | Oct 11, 2023 |  |
| AOA | AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M | Series A | Oct 11, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [LabCorp Venture Fund](https://shizune.co/investors/profile/labcorp-venture-fund) — VC Fund, 3 deals together
- [Adaptive Capital Partners](https://shizune.co/investors/profile/adaptive-capital-partners) — VC Fund, 2 deals together
- FemHealth Ventures — VC Fund, 2 deals together
- [Good Growth Capital](https://shizune.co/investors/profile/good-growth-capital) — VC Fund, 2 deals together
- Gore Range Capital — VC Fund, 2 deals together
- [LongeVC](https://shizune.co/investors/profile/longevc) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Cancer Fund invest in?

Cancer Fund invests primarily in Health Care, Medical and Biotechnology startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cancer Fund?

Public channels for Cancer Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Cancer Fund?

The team at Cancer Fund includes Ajay Bhatnagar (Chief Medical Officer), Anita Gupta (Venture Partner) and Ann Low (Co-Founder), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co